COVID-19-related encephalopathy responsive to high-dose glucocorticoids
Published inNeurology, vol. 95, no. 12, p. 543-546
Publication date2020
Keywords
- Betacoronavirus
- Brain Diseases/cerebrospinal fluid/diagnostic imaging/drug therapy/etiology
- COVID-19
- Cerebral Angiography
- Consciousness Disorders/drug therapy/etiology
- Coronavirus Infections/complications/therapy
- Endarteritis/cerebrospinal fluid/diagnostic imaging/drug therapy/etiology
- Endothelium
- Vascular/diagnostic imaging
- Glasgow Coma Scale
- Glucocorticoids/administration & dosage
- Humans
- Inflammation/diagnostic imaging/drug therapy
- Magnetic Resonance Angiography
- Magnetic Resonance Imaging
- Methylprednisolone/administration & dosage
- Oligoclonal Bands/cerebrospinal fluid
- Pandemics
- Pneumonia
- Viral/complications/therapy
- Recovery of Function
- Respiration
- Artificial
- Respiratory Distress Syndrome/etiology/therapy
- SARS-CoV-2
Affiliation entities
Citation (ISO format)
PUGIN, Deborah et al. COVID-19-related encephalopathy responsive to high-dose glucocorticoids. In: Neurology, 2020, vol. 95, n° 12, p. 543–546. doi: 10.1212/WNL.0000000000010354
Main files (1)
Article (Published version)
Identifiers
- PID : unige:156924
- DOI : 10.1212/WNL.0000000000010354
- PMID : 32680950
Journal ISSN0028-3878
